These findings suggest that MS17 may interfere with ubiquitination and proteasomal degradation by PSMA1 and PSMD13 to target multiple pathways and deregulate the protein expression, which could disrupt cancer progression and eventually lead to apoptosis. The gene discussed is PSMA1; the disease is cancer.